References
Lanford BE, Butel JS (1984) Construction and characterization of an SV40 nuclear transport of T antigen. Cell 37:801–813
Kalderon D, Richardson WD, Markham AF, Smith AE (1984) Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 311:33–38
Ritter W, Plank C, Lausier J, Rduolph C, Zink D, Reinhardt D, Rosenecker J (2003) A novel transfecting peptide comprising a tetrameric nuclear localization sequence. J Mol Med (http://dx.doi.org/10.1007/s00109-003-0483-2)
Saenz-Robles MT, Sullivan CS, Pipas JM (2001) Transforming functions of simian virus 40. Oncogene 20:7899–7907
McKay R, DiMaio D (1981) Binding of an SV 40 T antigen-related protein to the DNA of SV40 regulatory mutants. Nature 289:810–813
Cardoso MC, Leonhardt H (2002) Protein transduction: a novel tool for tissue regeneration. Biol Chem 383:1593–1599
Luft FC (1999) Can VP22 resurrect gene therapy? J Mol Med 77:575–576
Derer W, Easwaran HP, Leonhardt H, Cardoso MC (2002) A novel approach to induce cell cycle reentry in terminally differentiated muscle cells. FASEB J 16:312–313
Weis K (2003) Regualting access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112:441–451
Kohler M, Buchwalow IB, Alexander G, Christiansen M, Shagdarsuren E, Samoilova V, Hartmann E, Mervaala EM, Haller H (2001) Increased importin alpha protein expression in diabetic nephropathy. Kidney Int 60:2263–2273
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luft, F.C. What clinicians should know about SV40 large T antigen and nucleocytoplasmic transport. J Mol Med 81, 675–677 (2003). https://doi.org/10.1007/s00109-003-0487-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-003-0487-y